The Biden administration appoints a new coordinator for its global coronavirus response; more infectious COVID-19 variant first identified in United Kingdom now in all 50 states; spotlighting the impact of COVID-19 on the heart of an athlete.
In an effort to combat growing concerns of vaccine inequity worldwide, the Biden administration announced yesterday the appointment of Gayle Smith, a former director of the US Agency for International Development, to serve as the new coordinator for its global coronavirus response. Reported by The Washington Post, part of Smith’s responsibility will be to mobilize US resources and bolster vaccine production and distribution across the world. Globally, COVID-19 deaths surpassed 3 million today, with Brazil and India currently experiencing significant spikes in cases and deaths.
Reported by CNN, the COVID-19 variant first identified in the United Kingdom, B117, has now been identified in all 50 states, with more than 15,000 cases reported nationwide. Noted as more infectious, and potentially more deadly, existing vaccines have been found to be effective against the variant, although health experts are concerned that the United States may not be able to administer vaccines fast enough to avoid another surge. Cases of the more infectious P.1 COVID-19 variant first identified in Brazil have also been on the rise nationwide, as Massachusetts now accounts for about a quarter of cases of the variant, at 58, followed by Florida’s 55 cases.
In a piece by Kaiser Health News, the impact of COVID-19 on the heart of an athlete was spotlighted. With heart inflammation, known as myocarditis, affecting as many as 1 in 5 people infected with SARS-CoV-2, concern has been noted on whether this could put athletes at risk for lifelong complications and death, particularly if athletes return to play too soon. Although screening studies of collegiate athletes over the past year have found generally lower numbers, authors say that these studies have been too small to provide an accurate measure of how likely athletes are to develop heart issues due to the virus.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
2 Commerce Drive
Cranbury, NJ 08512